^
No biomarker
BCC
fluorouracil topical
Sensitive
:
A1
No biomarker
BCC
vismodegib
Sensitive
:
A1
No biomarker
BCC
imiquimod
Sensitive
:
A1
No biomarker
BCC
sonidegib
Sensitive
:
A1
No biomarker
BCC
cemiplimab
Sensitive
:
A1
No biomarker
BCC
celecoxib
Resistant
:
A2
SMO mutation
BCC
vismodegib
Resistant
:
B
PD-L1 expression
BCC
pembrolizumab
Sensitive
:
C1
TMB-H
BCC
Immunotherapy
Sensitive
:
C3
GLI1 overexpression
BCC
vismodegib
Resistant
:
C3
GAS1 underexpression
BCC
vismodegib
Sensitive
:
C3
SMO W535L
BCC
sonidegib
Resistant
:
C4
SMO Q477E
BCC
sonidegib
Resistant
:
C4
SMO D473H
BCC
sonidegib
Resistant
:
C4
SMO S533N
BCC
sonidegib
Resistant
:
C4
SMO D473G
BCC
sonidegib
Resistant
:
C4
PTCH1 1504-1G>T + TMB-H
BCC
nivolumab + vismodegib
Sensitive
:
C4
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our